China Medical System Holdings Limited(AIM:CMSH) is pleased to announce its participation in “Seminar of Development on the Diagnosis & Treatment in Autoimmune LIver Disease“ which was held in 20 December 2008 in Shanghai.
CMS sponsored this seminar during which more than 60 top experts from the field of autoimmune liver disease all over china discussed the development of diagonisis and treatment for the disease in China， and shared the latest international research results and trends.Moreover， the experts affirmed that “Ursofalk“ is the first choice when treating autoimmune liver disease.
About “Seminar of Development on the Diagnosis & Treatment in Autoimmune Liver Disease“
“Seminar of Development on the Diagnosis & Treatment in Autoimmune Liver Disease“ is hosted by Shanghai Research Institute of Digestive Disease，Society of Digestive Disease， Chinese Medical Association，and Society of Hepatology of Shanghai Medical Association. More than 60 top experts from this field all over China attended the seminar. The seminar possesses guiding significance for the development of diagnosis and treatment for autoimmune liver disease in China.